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ell adhesions play an important role in neurite ex-
tension. Paxillin, a focal adhesion adaptor protein
involved in focal adhesion dynamics, has been
demonstrated to be required for neurite outgrowth. How-
ever, the molecular mechanism by which paxillin regulates
neurite outgrowth is unknown. Here, we show that paxillin
is phosphorylated by p38MAPK in vitro and in nerve
growth factor (NGF)–induced PC-12 cells. Ser 85 (Ser 83 for
endogenous paxillin) is identiﬁed as one of major phos-
phorylation sites by phosphopeptide mapping and mass
 
spectrometry. Moreover, expression of the Ser 85 
 
→
 
 Ala
C
 
mutant of paxillin (pax
 
S85A
 
) signiﬁcantly inhibits NGF-induced
neurite extension of PC-12 cells, whereas expression of
wild-type (wt) paxillin does not inﬂuence neurite outgrowth.
Further experiments indicate that cells expressing pax
 
S85A
 
exhibit small, clustered focal adhesions which are not nor-
mally seen in cells expressing wt paxillin. Although wt pax-
illin and pax
 
S85A
 
 have the same ability to bind vinculin and
focal adhesion kinase, wt paxillin more efﬁciently associates
with Pyk2 than pax
 
S85A.
 
 Thus, phosphorylation of paxillin is
involved in NGF-induced neurite extension of PC-12 cells,
probably through regulating focal adhesion organization.
 
Introduction
 
Paxillin is a focal adhesion–associated adaptor protein involved
in adhesion organization and cell migration (for review see
Schaller, 2001). Its structure features five copies of a 13–amino
acid sequence, called the LD motif in the NH
 
2
 
-terminal half
and four LIM domains in the COOH-terminal half (Turner
and Miller, 1994; Salgia et al., 1995). A number of adhesion
or signaling molecules, such as vinculin, integrin 
 
 
 
 4 and 9,
FAK, cell adhesion kinase 
 
 
 
, integrin-linked kinase, PTP-
PEST, paxillin-kinase linker, and its homologous Git1 and
Git2 proteins, bind to paxillin largely through LD motif or
LIM domain interactions (for review see Schaller, 2001).
The NH
 
2
 
-terminal half of paxillin also contains a large
number of Ser-Pro epitopes, which are potential substrates
for proline-directed protein kinases (Pearson and Kemp, 1991;
Seger and Krebs, 1995). Indeed, it has been demonstrated that
c-jun NH
 
2
 
 terminus kinase (JNK) phosphorylates paxillin at
Ser178 in vitro and in vivo (Huang et al., 2003). Several
protein kinases including Erk and p38MAPK, have been
proposed to phosphorylate paxillin based on observations
using chemical inhibitors (Vadlamudi et al., 1999; Ku and
Meier, 2000; Liu et al., 2002), but due to the potential lack
of specificity of these inhibitors, the results remain to be
confirmed more directly. Paxillin is also a potential substrate
for cdk5, a proline-directed protein kinase that is enriched in
neuronal tissues and regulates neurite outgrowth (Nikolic et
al., 1996, 1998; Zukerberg et al., 2000), because paxillin
contains a consensus sequence (S/T)PX(K/H/R) for cdk5.
Integrin-mediated adhesions are essential for the neurite
outgrowth (Ivankovic-Dikic et al., 2000; Rhee et al., 2000;
Vogelezang et al., 2001). Thus, it is important to understand
how signaling pathways regulate cell adhesion dynamics
during the process of neurite outgrowth. Paxillin is a focal
adhesion–associated adaptor protein involved in the regulation
of focal adhesion dynamics (Liu et al., 1999; Schaller 2001;
Hagel et al., 2002; Huang et al., 2003). It has been demon-
strated that paxillin plays a key role in neurite outgrowth
(Ivankovic-Dikic et al., 2000). Moreover, expression of the
v-crk oncogene protein, the binding partner for tyrosine
phosphorylated paxillin, in PC12 cells promotes neurite
outgrowth by both NGF and EGF-dependent pathways
(Hempstead et al., 1994), but tyrosine phosphorylation of
paxillin does not seem to be essential for the neurite outgrowth
of PC-12 cells (Ivankovic-Dikic et al., 2000). Phosphorylation
of Ser 178 on paxillin by JNK has been shown to play a key
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role in cell migration (Huang et al., 2003). It has been found
that paxillin band is shifted to higher molecular weight in
SDS-PAGE when PC-12 cells are stimulated with NGF
(Rhee et al., 2000), suggesting that serine phosphorylation of
paxillin also increases upon NGF treatment, but the signal-
ing pathways involved and the physiological role are un-
known. In this paper, we demonstrate that paxillin is phos-
phorylated at Ser 85 by p38MAPK and cdk5/p35 in vitro,
and p38MAPK is the major kinase responsible for the phos-
phorylation of Ser 85 on paxillin in NGF-stimulated PC-12
cells. Furthermore, p38MAPK-mediated phosphorylation of
Ser 85 on paxillin is involved in NGF-induced neurite out-
growth of PC-12 cells.
 
Results
 
NGF induces paxillin phosphorylation in PC-12 cells
 
To confirm NGF-stimulated paxillin phosphorylation in
PC-12 cells, the cells were metabolically labeled with
[
 
32
 
P]orthophosphate and treated with NGF. The endoge-
nous paxillin was immunoprecipitated with antipaxillin an-
tibodies. The samples were separated by SDS-PAGE and
transferred to a nitrocellulose membrane. The phosphoryla-
tion of paxillin was detected by autoradiography. As shown
in Fig. 1 A, phosphorylation of paxillin was significantly en-
hanced by NGF stimulation and was partially inhibited by
PD98059, an Erk pathway inhibitor. The paxillin bands
from Fig. 1 A were excised, digested with trypsin, and sub-
jected to 2-dimensional (2-D) phosphopeptide mapping
analysis. One major spot (Fig. 1 B, arrow) was observed on
the 2-D maps of paxillin from NGF-treated cells, and stimu-
lation with NGF caused a dramatic increase in the intensity
of the spot (Fig. 1 B). The increase was partially inhibited by
PD98059, indicating that Erk pathway may be involved in
the phosphorylation of paxillin in PC-12 cells.
 
cdk5, p38MAPK, and Erk are activated upon 
NGF stimulation
 
To dissect the signaling pathway involved in the NGF-stimu-
lated phosphorylation of paxillin, PC-12 cells were challenged
with NGF for different times and the activation of several
candidate kinases were examined. To determine the activation
of cdk5, the cells were lysed with a Triton lysis buffer and
cdk5 was immunoprecipitated from cell lysates. The cdk5 ac-
tivities in the immunoprecipitates were measured in an in
vitro kinase assay using His-tagged paxillin as substrate. As
shown in Fig. 2 A, cdk5 activity slowly increased with a simi-
lar time course as the NGF-induced paxillin phosphorylation.
The activation of p38MAPK and Erk was examined by West-
ern blot using phospho-specific antibodies. The phosphoryla-
tion of p38MAPK exhibited a sustained increase from 30 min
after NGF stimulation and dropped after 3 h (Fig. 2 B),
whereas the activation of Erk reached a peak as early as 30 min
and slowly went down (Fig. 2 C). In a similar experiment, the
activation of JNK was not detected upon NGF stimulation
(unpublished data). Thus, cdk5, p38MAPK and Erk are the
potential protein kinases responsible for the NGF-stimulated
paxillin phosphorylation in PC-12 cells.
 
cdk5 and p38MAPK phosphorylates Ser 85 
on paxillin in vitro
 
To learn which protein kinase may be responsible for the
NGF-induced paxillin phosphorylation, three kinases were
tested for their ability to phosphorylate paxillin in vitro.
Therefore, recombinant paxillin 
 
 
 
 was phosphorylated with
cdk5/p35, p38MAPK, and erk/MAPK in vitro in the pres-
ence of 
 
 
 
-[
 
32
 
P]ATP, and the phosphorylated paxillin was
digested with trypsin and analyzed by 2-D phosphopeptide
mapping. As shown in Fig. 3 A, two major spots (a and b)
were observed on the 2-D map of cdk5-phosphorylated
Figure 1. NGF-stimulated paxillin phosphorylation in PC-12 cells 
and PD98059 partially inhibited the phosphorylation. Cells were 
cultured in tissue culture dishes, labeled, treated with 25  M PD98059 
as indicated for 10 min, and stimulated with 100 ng/ml NGF for times 
as indicated. Cells were then lysed and paxillin was immunoprecipi-
tated from cell lysates with antipaxillin mAb. Paxillin phosphorylation 
was analyzed as described in Materials and methods. Total phos-
phorylation of paxillin (A) and the corresponding phosphopeptide 
mapping analysis (B) were shown. The origins are marked by dots. 
One major spot is pointed to by an arrow.
Figure 2. NGF-activated cdk5, p38MAPK, and erk/MAPK in PC–12 
cells. (A) Cells were treated with NGF for different times as indicated 
and lysed. cdk5 was immunoprecipitated from cleared cell lysates and 
cdk5 activities were measured by in vitro kinase assays using 5  g 
paxillin as substrates. (B and C) Cells were treated with NGF for 
different times as indicated and lysed in SDS sample buffer. The 
samples were applied to SDS-PAGE, transferred to nitrocellulose 
membrane, probed with (B) anti–phospho-p38MAPK or (C) anti–
phospho-erk/MAPK antibodies to detect the activation of the kinases. 
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paxillin 
 
 
 
. Substitution of Ser 244 (the consensus site for
cdk5) with alanine resulted in the disappearance of spot a
(Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200307081/DC1), indicating that Ser 244 is a phos-
phorylation site for cdk5 in vitro. The polymorphism of
spot a is probably caused by the high molecular mass of the
phosphopeptide (4249.59 D). Spot b is more interesting
because it migrates to the same position as the major spot of
in vivo phosphorylation (see Fig. 4 B). A similar spot also
existed in the 2-D map of p38MAPK-phosphorylated paxil-
lin, whereas a very weak spot was observed in the same posi-
tion of the map of Erk-phosphorylated paxillin (Fig. 3 A).
To identify the phosphorylation site corresponding to
spot b, the phosphopeptide at the spot was recovered from
the cellulose plate and subjected to mass spectrometry. The
parent ion was observed at m/z 2028.1656, corresponding
to paxillin peptide 76-FIHQQPQSSSPVYGSSAK-93 with
one phosphoryl group. A fragment ion was also detected at
m/z 1930.2837, which is equivalent to the m/z of the same
peptide minus 98. The coexistence of this precursor ion and
its minus 98 counterpart ion indicates that a phosphoryla-
tion site is located on peptide FIHQQPQSSSPVYGSSAK.
Further MS/MS analysis of the parent ion revealed the pres-
ence of a phosphoryl group at Ser 85 because the additional
mass of the phosphoryl group occurs at the b
 
10
 
 ion and the
y
 
9
 
 ion and all subsequent b and y ions, but not at b
 
3
 
-b
 
5
 
, b
 
7
 
-
b
 
9
 
, y
 
6
 
, and y
 
8
 
 ions that do not contain Ser 85 (Fig. 3 B). The
observation of the loss of 98 of the b
 
10
 
 ion (b
 
10
 
-H
 
3
 
PO
 
4
 
) ad-
ditionally confirms the phosphorylation of Ser 85 by cdk5
and p38MAPK in vitro. This conclusion was confirmed by
site-directed mutagenesis. As shown in Fig. 3 A, the spot b is
absent in the 2-D maps of paxillin phosphorylated by cdk5
and p38. Thus, Ser 85 of paxillin is one of the major resi-
dues targeted by cdk5 and p38MAPK in vitro.
 
Ser 85 is also phosphorylated in NGF-stimulated 
PC-12 cells
 
To learn whether Ser 85 on paxillin is also phosphorylated
in NGF-stimulated PC-12 cells, the cells were transfected
with EGFP-paxillin 
 
 
 
 and labeled with [
 
32
 
P]orthophos-
phoric acid. EGFP-paxillin 
 
 
 
 was immunoprecipitated with
an anti-GFP antibody. The samples were separated by SDS-
PAGE and transferred to a nitrocellulose membrane. The
phosphorylation of EGFP-paxillin 
 
 
 
 was detected by autora-
diography. As shown in Fig. 4 A, phosphorylation of paxillin
 
 
 
 was significantly enhanced by NGF stimulation (Contl
and NGF 3hr). The paxillin bands from Fig. 4 A were ex-
cised, digested with trypsin, and subjected to 2-D phospho-
peptide mapping analysis. The map of transfected EGFP-
Figure 3. cdk5 and p38MAPK directly phosphorylated Ser 85 on 
paxillin in vitro. (A) His-tagged paxillin   or paxS85A were incubated, 
respectively, with active cdk5/p35, p38MAPK, and erk/MAPK in 50  l 
of kinase buffer containing 40  M  -[
32P]ATP (10  Ci) for 30 min. The 
phosphorylation of paxillin   and paxS85A (not depicted) and 2-D 
phosphopeptide mapping were analyzed. The origins are marked by 
dots. Two major spots are pointed to by arrows a and b, respectively. 
(B) MS/MS analysis of a phosphopeptide recovered from spot b.
Figure 4. Paxillin was phosphorylated at the same site in vitro and 
in NGF-stimulated PC-12 cells, and the phosphorylation was not 
influenced by a cdk5 inhibitor, roscovitine. PC-12 cells stably 
expressing EGFP-paxillin   or -paxS244A were cultured in collagen-
coated dishes, labeled, treated with 100  M roscovitine (Ros) as 
indicated for 10 min, and stimulated with 100 ng/ml NGF for 3 h. 
Cells were then lysed and EGFP fusion proteins was immunoprecip-
itated from cell lysates with anti-GFP pAb. Total phosphorylation of 
EGFP-paxillin   or EGFP-paxS244A (A) and the corresponding phos-
phopeptide mapping analysis (B) were analyzed as described in 
Materials and methods. A sample from in vitro phosphorylation and 
a mixed sample containing paxillin phosphopeptide from in vitro 
phosphorylation and NGF-stimulated PC-12 cells were also analyzed 
by 2-D phosphopeptide mapping. The origins are marked by dots. 
596 The Journal of Cell Biology 
 
|
 
 
 
Volume 164, Number 4, 2004
 
paxillin is somewhat different from that of endogenous pax-
illin from PC-12 cells (Fig. 1 B), probably due to the species
difference of paxillin. Three major spots were observed on
the 2-D maps of EGFP-paxillin 
 
 
 
, and treatment with NGF
caused an increase in the intensity of the spots (Fig. 4 B).
Furthermore, the spot b (Fig. 4 B, arrow) comigrated with
the major spot from the 2-D map of in vitro phosphorylated
paxillin 
 
 
 
 (Fig. 4 B). Therefore, paxillin is phosphorylated at
the same site in vitro and in PC-12 cells.
 
NGF-induced phosphorylation of Ser 85 on paxillin 
is not inhibited by roscovitine and is only slightly 
impaired by purvalanol
 
Next, we asked whether paxillin is a substrate for cdk5 in
NGF-stimulated PC-12 cells. The EGFP-paxillin 
 
 
 
–trans-
fected cells were labeled with [
 
32
 
P]orthophosphoric acid, pre-
incubated with 50 
 
 
 
M roscovitine, a cdk5 inhibitor for 10
min, and then stimulated with NGF for 3 h. The phosphory-
lation of EGFP-paxillin 
 
 
 
 was examined as described in the
previous paragraph. As shown in Fig. 4 A, the NGF-induced
phosphorylation of paxillin 
 
 
 
 was not inhibited by roscovitine
(NGF 3hr and Ros
 
 
 
NGF). Further 2-D phosphopeptide
analysis confirmed that no major spot in the map is inhib-
ited by roscovitine. Purvalanol, another cdk5 inhibitor, only
slightly inhibited the phosphorylation of Ser 85 on paxillin in
NGF-stimulated PC-12 cells (Fig. 5 B), whereas the total
phosphorylation (Fig. 5 A, Purvalanol
 
 
 
NGF 3hr) and several
other spots on the map (Fig. 5 B) were inhibited. Further-
more, substitution of Ser 244, the major cdk5-targeted site in
vitro, with alanine had no any significant effect on either the
total phosphorylation (Fig. 4 A, Contl and NGF 3hr under
S244A) or the major spots on the phosphopeptide map (Fig. 4
B). Therefore, cdk5 is not the kinase responsible for the phos-
phorylation of Ser 85 on paxillin in NGF-stimulated cells.
 
Phosphorylation of Ser 85 is abolished by SB203580, 
a p38MAPK inhibitor
 
Next, we examined whether SB203580, a p38MAPK inhib-
itor, influenced the phosphorylation of Ser 85 on paxillin.
As shown in Fig. 5 A, the phosphorylation of EGFP-paxillin
 
 
 
 was significantly inhibited by SB203580 (Fig. 5 A), and
2-D phosphopeptide mapping analysis showed that the
phosphorylation of Ser 85 was completely abolished and sev-
eral other spots on the map were inhibited by SB203580
(Fig. 5 B). This result suggests that the phosphorylation of
Ser 85 on paxillin is largely mediated by p38MAPK in
NGF-stimulated PC-12 cells.
 
Endogenous paxillin is phosphorylated at Ser 83 
in NGF-stimulated PC-12 cells
 
To identify the major p38 phosphorylation sites on rat paxil-
lin, the protein was isolated from a rat bladder tumor cell line
(NBT-II), and phosphorylated with p38MAPK in vitro. The
phosphorylated paxillin was subjected to 2-D mapping analy-
sis. As shown in Fig. 6 A, there was one major phosphorylation
spot on the map. To identify the phosphorylation site, phos-
phopeptides were recovered from that spot and analyzed by
mass spectrometry. The parent ion was detected at m/z
2054.9556, which is identical to the calculated m/z of pep-
 
tide 76-YAHQQPPSPSPIYSSSTK-93 with one phosphoryl
group. This peptide is homologous to human paxillin peptide
76-FIHQQPQSSSPVYGSSAKA-93 (Fig. 6 C). A fragment
ion was also detected at m/z 1956.9556, which is equivalent to
the m/z of the same peptide minus 98, indicating that peptide
YAHQQPPSPSPIYSSSTK contains a phosphorylation site.
The observation of the loss of 98 of the b
 
8
 
 ion (b
 
8
 
-H
 
3
 
PO
 
4
 
) in-
dicates that a phosphorylation site is located on fragment 76-
YAHQQPPS-83, whereas the additional mass of the phos-
phoryl group was not detected at the b
 
3
 
-b
 
7
 
 ions (Fig. 6 B). Thus,
Ser 83 on rat paxillin is phosphorylated by p38MAPK in vitro.
To learn whether endogenous paxillin is also phosphory-
lated at Ser 83 in NGF-induced PC-12 cells, endogenous
paxillin was immunoprecipitated from [
 
32
 
P]orthophosphoric
acid–labeled, NGF-stimulated PC-12 cells and separated by
SDS-PAGE. The paxillin band was isolated, digested, and
subjected to 2-D peptide mapping analysis. The endogenous
paxillin sample from PC-12 cells was also mixed with the in
vitro paxillin sample and subjected to 2-D peptide mapping
analysis. As shown in Fig. 6 A, a spot on the map of paxillin
from PC-12 cells comigrated with a phosphopeptide from
paxillin phosphorylated in vitro, indicating that endogenous
paxillin was also phosphorylated at Ser 83 in NGF-stimu-
lated PC-12 cells.
 
p38MAPK-mediated phosphorylation of paxillin 
is involved in NGF-induced neurite extension
 
To explore the role of p38MAPK in neurite extension, the
effect of SB203580 on NGF-induced neurite extension in
Figure 5.  Phosphorylation of Ser 85 on paxillin was abolished by 
a p38MAPK inhibitor SB203580. PC-12 cells stably expressing 
EGFP-paxillin   was cultured in collagen-coated dishes, labeled, 
treated with 50  M purvalanol or 20  M SB203580 as indicated for 
10 min, and stimulated with 100 ng/ml NGF for 3 h. Cells were then 
lysed and EGFP-paxillin   was immunoprecipitated from cell lysates 
with anti-GFP antibody. Total phosphorylation of EGFP-paxillin   (A) 
and the corresponding phosphopeptide mapping analysis (B) were 
analyzed as described in Materials and methods. The origins are 
marked by dots. The phosphorylation of Ser 85 is pointed to by arrows. 
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PC-12 cells was examined. About 46% of control cells had
neurites longer than two cell bodies and 28% of the cells had
neurites longer than three cell bodies. Treatment with
SB203580 inhibited neurite outgrowth. In the presence of
10 
 
 
 
M SB203580 only 19% of cells extended neurites
longer than two cell bodies and 7% extended neurites longer
than three cell body lengths. Treatment with 20 
 
 
 
M of
SB203580 almost abolished the NGF-induced neurite ex-
tension of PC-12 cells (Fig. S2, A and B, available at http://
www.jcb.org/cgi/content/full/jcb.200307081/DC1).
To assess the role of p38MAPK-mediated paxillin phos-
phorylation in neurite extension, PC-12 cells were trans-
fected with EGFP-paxillin 
 
 
 
 or -pax
 
S85A
 
, and the NGF-
induced neurite extension of these cells was examined. As
shown in Fig. 7, whereas cells expressing EGFP-pax
 
S85A
 
 ex-
hibited 
 
 
 
20% of cells bearing neurites longer than two cell
bodies and 7% of cells producing neurites longer than three
cell bodies, 
 
 
 
50% of cells expressing wild-type (wt) EGFP-
paxillin 
 
 
 
 had neurites longer than two cell bodies and
 
 
 
32% of cells had neurites longer than three cell bodies. Ex-
Figure 6. Phosphorylation of endogenous paxillin at Ser 83 
in NGF-stimulated PC-12 cells. (A) Endogenous paxillin in 
PC-12 cells is phosphorylated at the same site where p38MAPK 
targeted paxillin in vitro. Rat bladder tumor cells (NBT-II) was 
lysed in a buffer containing 50 mM Tris-HCl, pH 7.4, 140 mM 
NaCl, 1% Triton X-100, 1 mM PMSF, 10  g/ml aprotinin, 
10  g/ml leupeptin, and 10  g/ml pepstatin. Rat paxillin was 
pulled down by GST-FAT immobilized to glutathione beads 
(Thomas et al., 1999). Bound proteins were eluted from beads 
with glutathione and phosphorylated with p38MAPK. Paxillin 
was subjected to 2-D phosphopeptide mapping analysis 
(middle). The phosphorylation of endogenous paxillin from 
NGF-stimulated PC-12 cells was also analyzed (left). A mixed 
sample containing paxillin phosphopeptide from in vitro 
phosphorylation and NGF-stimulated PC-12 cells were also 
analyzed by 2-D phosphopeptide mapping (right). The spots 
that comigrated are pointed by arrowheads. The origins are 
marked by dots. (B) Rat paxillin is phosphorylated at Ser 83 
by p38MAPK. MS/MS analysis of a phosphopeptide recovered 
from the major spot (arrow) in middle panel of A. (C) The 
major phosphopeptide from rat paxillin is homologous to the 
phosphopeptide from human paxillin.
 
Figure 7.
 
Expression of pax
 
S85A
 
 inhibited NGF-induced neurite 
extension in PC-12 cells.
 
 Cells stably expressing EGFP-paxillin 
 
 
 
 
or -pax
 
S85A
 
 were plated on collagen-coated petri dishes and treated 
with 100 ng/ml NGF as described in Materials and methods. The 
neurite outgrowth was recorded after 96 h of NGF stimulation. (A) 
Typical inhibition of NGF-induced neurite extension by expression of 
pax
 
S85A
 
. Bar, 40 
 
 
 
m. (B) Quantitative analysis of neurite outgrowth 
from 
 
 
 
300 cells. The data was plotted as the mean 
 
  SD from three 
experiments.598 The Journal of Cell Biology | Volume 164, Number 4, 2004
pression of wt EGFP-paxillin had no effect on neurite exten-
sion of PC-12 cells, which is consistent with a recent report
by Ivankovic-Dikic et al. (2000). Therefore, phosphorylation
of paxillin is involved in NGF-induced neurite extension.
p38MAPK-mediated phosphorylation of paxillin 
is involved in the regulation of focal adhesions
To understand the role of phosphorylation of paxillin at Ser
85 in focal adhesion organization, the focal adhesions in PC-
12 cells expressing EGFP-paxillin   or EGFP-paxS85A were ex-
amined with TIRF and epifluorescence microscopy. EGFP-
paxillin   localized to focal adhesions at the tips of cell pro-
cesses (arrows), whereas EGFP-paxS85A was more clustered in
focal adhesions at the tips (arrows) and there appeared to be an
increase in the number of focal adhesions (Fig. 8, A and B;
Fig. 9). Staining these cells with Alexa 568–labeled antivincu-
lin antibodies gave a similar result and showed that vinculin
colocalized with paxillin at the tips of cell processes (Fig. 9).
These results also demonstrate that changes in EGFP-paxillin
fluorescence reflect changes in focal adhesion structure rather
than simply changes in paxillin localization. Expression of a
p38MAPK dominant negative mutant (p38 AF) also induced
the formation of more clustered focal adhesions, whereas ex-
pression of MKK3bE, a constitutively active MAPK kinase for
p38MAPK, induces focal adhesion disassembly in PC-12 cells
(Fig. S3, arrows, available at http://www.jcb.org/cgi/content/
full/jcb.200307081/DC1). Thus, phosphorylation of paxillin
by p38MAPK plays an important role in focal adhesion orga-
nization in NGF-stimulated PC-12 cells.
p38MAPK-mediated phosphorylation of paxillin 
influences the binding of Pyk2 to paxillin
To explore the possible mechanism by which paxillin phos-
phorylation regulates neurite extension and cell adhesions, ty-
rosine phosphorylation of EGFP-paxillin  , EGFP-paxS85A,
FAK, and Src, in NGF-treated PC-12 cells expressing EGFP-
paxillin   or EGFP-paxS85A were examined using antiphos-
photyrosine or phospho-specific antibodies. As shown in Fig.
10 (A and B), the tyrosine phosphorylation of these molecules
was not changed by expressing EGFP-paxS85A, suggesting that
phosphorylation of paxillin by p38MAPK is not involved in
regulating the tyrosine phosphorylation of these proteins.
Because paxillin is a focal adhesion adaptor interacting
with a number of signaling and adhesion proteins, such as
vinculin, FAK, and Pyk2, we tested the interaction of EGFP-
paxillin and EGFP-paxS85A with these molecules in NGF-
induced cells, respectively. Although EGFP-paxillin and
Figure 8. Expression of paxS85A enhanced focal adhesion formation 
in NGF-treated PC-12 cells. Cells stably expressing EGFP-paxillin   
or EGFP-paxS85A were plated on collagen-coated MatTek dishes and 
treated with 100 ng/ml NGF for 36 h. TIRF and epifluorescence 
images were taken as described in Materials and methods. (A) Expres-
sion of paxS85A induced clustered focal adhesions. Arrows point to 
focal adhesions. Bar, 20  m. (B) Quantitative analysis of focal adhe-
sions in PC-12 cells expressing EGFP-paxillin   or EGFP-paxS85A. The 
data was analyzed using Metamorph software and focal contacts that 
were longer than five pixels (1  m) were scored.
Figure 9. Vinculin was colocalized with paxillin at the tips of neu-
rites. Cells stably expressing EGFP-paxillin   or EGFP-paxS85A were 
plated on collagen-coated MatTek dishes and treated with 100 ng/ml 
NGF for 48 h. The cells were fixed and stained with Alexa 568–labeled 
antivinculin antibodies. TIRF images of EGFP-paxillin   or EGFP-
paxS85A (top) and vinculin (bottom) were taken as described in 
Materials and methods. Bar, 20  m.p38MAPK phosphorylates paxillin during neurite extension | Huang et al. 599
EGFP-paxS85A had the same ability to bind vinculin and
FAK, EGFP-paxillin more efficiently associated with Pyk2
than EGFP-paxS85A (Fig. 10 B). Because phosphorylation of
paxillin by p38MAPK in vitro had no significant effect on its
binding to Pyk2, it is unclear how phosphorylation of paxil-
lin influences the interaction between paxillin and Pyk2.
Nevertheless, because Pyk2 is involved in regulating neurite
extension and focal adhesions (Ivankovic-Dikic et al., 2000;
Park et al., 2000; Taniyama et al., 2003), the interaction of
paxillin with Pyk2 may play a role in these processes.
Discussion
p38MAPK plays an important role in neurite extension
It has been demonstrated that sustained activation of Erk and
the consequent stimulation of cdk5 are involved in neurite
outgrowth in many systems (Qui and Green, 1992; Harada
et al., 2001; Desbarats et al., 2003). However, it has been re-
ported that inhibition of sustained phase of Erk activation
does not block neurite outgrowth (York et al., 1998). Also,
c-Src and bone morphogenetic protein 2 are unable to in-
duce the activation of Erk but still induce neurite outgrowth
(Iwasaki et al., 1999; Yang et al., 2002), indicating that mul-
tiple signaling pathways are involved in neurite outgrowth.
Several lines of evidence indicate that p38MAPK is essen-
tial for neurite outgrowth. First, SB203580, an inhibitor
of p38MAPK, blocks neurite outgrowth in several systems
(Morooka and Nishida, 1998; Iwasaki et al., 1999; Hansen et
al., 2000; Ishii et al., 2001). Second, a dominant negative mu-
tant of p38MAPK also inhibits neurite outgrowth induced by
NGF and forskolin (Morooka and Nishida, 1998; Hansen et
al., 2000). Third, activation of p38MAPK by expressing con-
stitutively active MKK3/MKK6, the kinases that phosphory-
late and activate p38, induces neurite outgrowth in the ab-
sence of growth factor stimulation (Iwasaki et al., 1999).
Paxillin is a substrate for p38MAPK in vitro and in 
NGF-stimulated cells
It has been suggested that paxillin is a substrate for Erk in
hepatocyte growth factor–stimulated epithelial and PMA-
induced thymoma cells (Ku and Meier, 2000; Liu et al.,
2002). However, it is unclear whether paxillin is a direct
substrate for Erk in these cells. Here, we show that Erk2
phosphorylates paxillin in vitro at two major sites and that
Ser 85 is a minor phosphorylation site for Erk in vitro (Fig.
3), whereas Ser 85 of exogenously expressed human paxillin
(Ser 83 for the endogenous rat paxillin) is major site in
NGF-stimulated PC-12 cells (Fig. 4). Also, treatment of
PC-12 cells with PD98058 only partially inhibits NGF-
induced phosphorylation of Ser 83 (Fig. 1). The partial in-
hibition could be due to the indirect inhibition of p38MAPK
because it has reported that constitutive activation of
MEK1, the upstream kinase of Erk and the target for
PD98059, up-regulates p38MAPK activity in PC-12 cells
(Morooka and Nishida, 1998). Thus, Erk may be upstream
of paxillin, but may not be directly responsible for Ser 83
phosphorylation in NGF-stimulated PC-12 cells.
There is a consensus site (Ser 244) for cdk5 on paxillin.
Also, NGF induces paxillin phosphorylation with a similar
time course as cdk5 activation (Figs. 1 and 2). This had led
us to suspect that paxillin could be a substrate for cdk5 in
NGF-stimulated PC-12 cells. However, our experiments in-
dicate that Ser 244, the consensus and the major phosphory-
lation site for cdk5 in vitro, is not phosphorylated in NGF-
stimulated PC-12 cells (Fig. 4). Also, the phosphorylation of
Ser 85 is not significantly inhibited by two cdk5 inhibitors
(Figs. 4 and 5). Therefore, cdk5 is not involved in the phos-
phorylation of Ser 85 in PC-12 cells.
p38MAPK has been implicated in heregulin  1–induced
paxillin phosphorylation in breast cancer cells (Vadlamudi et
al., 1999). Paxillin phosphorylation induced by heregulin
 1 was partially inhibited by a p38 inhibitor SB203580 and
a dominant negative mutant of p38MAPK, but not by
PD98059 (Vadlamudi et al., 1999). Here, we show that
p38MAPK phosphorylates human paxillin at three major
sites in vitro (Fig. 3) and rat paxillin at one major site (Fig.
6). Ser 85 was unambiguously identified as one of the major
p38MAPK phosphorylation sites on human paxillin in vitro
and a major NGF-induced phosphorylation site of exoge-
nous paxillin in PC-12 cells (Figs. 3 and 4). Also, Ser 83 was
identified as the major p38MAPK phosphorylation site on
rat paxillin in vitro and a major phosphorylation site of en-
Figure 10. p38MAPK-mediated phosphorylation of paxillin influ-
ences the binding of Pyk2 to paxillin. PC-12 cells expressing EGFP-
paxillin   or EGFP-paxS85A were induced with 100 ng/ml NGF for 2 d. 
Cells were lysed and lysates were directly mixed with SDS sample 
buffer. Samples were analyzed by SDS-PAGE and transferred to 
nitrocellulose membrane for probing tyrosine phosphorylation of 
paxillin, FAK, and Src with phospho-specific antibodies (A). Alterna-
tively, the lysates were immunoprecipitated with anti-GFP antibodies. 
The immune complexes were solubilized in SDS sample buffer. 
Samples were analyzed for tyrosine phosphorylation of paxillin and 
paxillin binding of vinculin, FAK, and Pyk2 (B).600 The Journal of Cell Biology | Volume 164, Number 4, 2004
dogenous paxillin in PC-12 cells (Figs. 1 and 6). Because the
sequence of rat paxillin around Ser 83 is homologous to that
of human paxillin around Ser 85, and the Ser 83 and Ser 85
sites are so close (Fig. 6 C), suggesting that the two sites are
likely comparable. Furthermore, the phosphorylation of
Ser 85 is completely abolished by a p38MAPK inhibitor
SB203580 in NGF-stimulated PC-12 cells (Fig. 5). Thus,
p38MAPK is a kinase that directly phosphorylates paxillin
in NGF-stimulated PC-12 cells.
Phosphorylation of paxillin is involved in neurite 
extension of PC-12 cells
The role of cell adhesions in neurite extension has been es-
tablished previously (Ivankovic-Dikic et al., 2000; Rhee et
al., 2000; Vogelezang et al., 2001). As an important compo-
nent of adhesions, paxillin is also involved in neurite out-
growth (Ivankovic-Dikic et al., 2000). Although expression
of wt paxillin does not influence the neurite outgrowth, ex-
pression of a LD4-deleted paxillin mutant significantly in-
hibits the neurite outgrowth of PC-12 cells (Ivankovic-Dikic
et al., 2000). Expression of v-Crk, an adaptor protein that
binds to tyrosine phosphorylated paxillin, promotes neurite
formation (Hempstead et al., 1994). Surprisingly, expres-
sion of paxillin mutant (Y31F, Y118F, Y187F), which is de-
ficient in tyrosine phosphorylation and unable to bind Crk,
has no effect on neurite extension (Ivankovic-Dikic et al.,
2000). This result indicates that tyrosine phosphorylation of
paxillin is not essential for neurite outgrowth in PC-12 cells.
Recently, we demonstrated that phosphorylation of Ser
178 on paxillin by JNK regulates cell migration in several
cell types (Huang et al., 2003). However, JNK is not acti-
vated and Ser178 is not phosphorylated in NGF-stimulated
PC-12 cells (unpublished data). Instead, the activity of
p38MAPK is up-regulated and the phosphorylation level of
Ser 85 increases. Moreover, expression of a paxillin mutant
paxS85A significantly retards NGF-induced neurite extension
(Fig. 7), indicating the involvement of phosphorylation of
Ser 85 by p38MAPK in NGF-induced neurite extension.
Thus, two types of different cell motility are regulated by
two related pathways through phosphorylating their com-
mon substrate-paxillin at distinct sites.
Paxillin phosphorylation by p38MAPK is also involved 
in cell adhesion reorganization
It has been reported that heregulin  1 induces p38MAPK ac-
tivation and serine phosphorylation on paxillin, resulting in
focal adhesion disassembly (Vadlamudi et al., 1999). In an-
other report, collagen I stimulates the activities of p38MAPK
accompanying a decrease in focal adhesion in endothelial cells,
without affecting MAPK kinase, focal adhesion kinase, or
phosphatidylinositol 3-kinase (Sweeney et al., 2003). It is
known that focal adhesions undergo reorganization when PC-
12 cells are induced to differentiate by NGF (Rhee et al.,
2000). Here, we show that either a p38MAPK dominant neg-
ative mutant or a paxillin mutant (paxS85A) cause clustered
focal adhesions, whereas MKK3bE, a constitutively active
MAPK kinase for p38MAPK, induces focal adhesion disas-
sembly when they are expressed in NGF-treated PC-12 (Figs.
8 and 9; Fig. S3), suggesting that paxillin phosphorylation by
p38MAPK is involved in focal adhesion organization.
How p38MAPK-mediated phosphorylation of paxillin
modulates focal adhesions and neurite extension remains to
be elucidated. The phosphorylation of paxillin may facilitate
the interaction of paxillin with Pyk2, a nonreceptor protein
tyrosine kinase that is involved in regulating focal adhesion
dynamics and neurite extension (Ivankovic-Dikic et al.,
2000; Park et al., 2000; Taniyama et al., 2003). Pyk2 may
in turn phosphorylate the Arf-GTPase–activating protein
ASAP1 and 3-phosphoinositide–dependent protein kinase 1,
or activate Rho pathway (Kruljac-Letunic et al., 2003; Oki-
gaki et al., 2003; Taniyama et al., 2003). All these signaling
events regulate focal adhesion dynamics and may modulate
neurite extension. However, other currently unknown mech-
anisms may also mediate the role of paxillin phosphorylation.
For example, we found that a phosphorylated degradation
product of paxillin ( 50 kD) was generated after NGF stim-
ulation in PC-12 cells (unpublished data), implying that pax-
illin phosphorylation may be involved in its degradation.
Further studies are required to understand the focal adhesion
dynamics during NGF-induced differentiation of PC-12 cells
and to fully elucidate the role of serine phosphorylation of
paxillin in the regulation of focal adhesion structure.
Materials and methods
Reagents
Active cdk5/p35 was purchased from Novagen; active p42MAPK was pur-
chased from New England Biolabs, Inc.; Trypsin (sequencing grade) was
purchased from Promega; and Flag-p38 , -p38 AF, and -MKK3bE in
pcDNA3.1 vector and His-tagged MKK6Eb were gifts from J. Han (Scripps
Research Institute, La Jolla, CA). Human paxillin cDNA was a gift from H.
Sabe (Osaka Bioscience Institute, Osaka, Japan). Zip-Tips were purchased
from Millipore; Ni-NTA-agarose and PQE-30 vector were purchased from
QIAGEN; Pfu and Quick-Change mutation kit were purchased from Strat-
agene; PD98059 and SB203580 were purchased from Calbiochem; rosco-
vitine, purvalanol, rat tail collagen I, antivinculin mAb, and NGF were pur-
chased from Sigma-Aldrich;  -[
32P]ATP was purchased from NEN Life
Science Products; [
32P]orthophosphate was purchased from ICN Biomedi-
cals; Alexa Fluor 568 protein labeling kit was purchased from Molecular
Probes; antipaxillin mAbs were purchased from Upstate Biotechnology;
anti-GFP pAbs were purchased from CLONTECH Laboratories, Inc.; and
rat phaeochromocytoma PC-12 cells were obtained from W. Snider’s lab
and cultured in RPMI 1640 supplemented with 10% horse serum, 5% FBS,
100 U/ml penicillin, and 100  g/ml streptomycin.
Plasmid construction
To generate His-tagged p38 , DNA fragments encoding p38  were ampli-
fied by pfu-based PCR using Flag-p38  as template and 5 -TTACTTG-
GATCCCAGGAGAGGCCCACGTTC-3  and 5 -TTTTTTCTGCAGTCAG-
GACTCCATTTCTTCTTGGTC-3  as primers, and subcloned into PQE-30
vector via BamHI and PstI sites. To create His-tagged paxillin  , DNA
fragments encoding paxillin   were amplified by pfu-based PCR using
5 -CGACGACCTCGACGCCCTG-3  and 5 -AAAAAAGTCGACCTAGCA-
GAAGAGCTTGAGGAAGCA-3  as primers, and subcloned into pQE-30
vector through Klenow-blunt BamHI site and SalI. His-tagged paxS85A was
created by pfu-based PCR using Quick-Change mutation kit and primer
pair 5 -CCTCAGTCCTCAGCACCTGTGTACGGC-3  and 5 -GCCGTACA-
CAGGTGCTGAGGACTGAGG-3 . To construct EGFP-paxillin   and
-paxS85A, DNA fragments encoding paxillin   and paxS85A were amplified
respectively by pfu-based PCR using primer pair 5 -AAAAAAGAATTCA-
GACGACCTCGACGCCCT-3  and 5 -AAAAAAGTCGACCTAGCAGAA-
GAGCTTGAGGAAGCA-3 , and subcloned into pEGFP-C1 vector through
EcoRI site and SalI. The DNA fragments encoding EGFP-paxillin   and
EGFP-paxS85A were cut out by sequential treatment with SalI, Klenow, and
AgeI and inserted into a retroviral MGIN vector (Li et al., 2000) through
AgeI and Klenow-blunt NotI sites.
Protein purification
His-tagged proteins were purified by affinity chromatography using Ni-
NTA-agarose. In brief, expression was induced with 1 mM IPTG for 3.5 h,p38MAPK phosphorylates paxillin during neurite extension | Huang et al. 601
bacteria harvested, and sonicated in a lysis buffer (50 mM Tris-HCl, pH
8.1, 300 mM NaCl, 1% Triton X-100, 1 mM PMSF, 10  g/ml aprotinin, 10
 g/ml leupeptin, 10  g/ml pepstatin, 20 mM imidazole). The cleared ly-
sate was applied to Ni-NTA-agarose column. His-tagged protein was
eluted with 250 mM imidazole in 20 mM Tris-HCl, pH 8.1, 300 mM NaCl.
Preparation of viruses and cell infection
Retrovirus packaging cells (293GPG) were maintained in DME supple-
mented with 10% FBS, 100 U/ml penicillin, 100  g/ml streptomycin, 1  g/
ml tetracycline, 2  g/ml puromycin, and 0.3 mg/ml G418. The cells were
transfected with MGIN plasmids using Lipofectamine Plus transfection re-
agent (Invitrogen) according to the manufacturer’s protocol. To harvest vi-
ruses, the transfectants were grown in DME supplemented with 10% FBS,
100 U/ml penicillin, and 100  g/ml streptomycin. The medium of trans-
fectants was collected at 48 and 72 h, filtered though 0.2-mm filter and ap-
plied to overnight cultures of PC-12 cells for infection. Cells stably express-
ing recombinant proteins were obtained by growing infected PC-12 cells
in the presence of 0.7 mg/ml G418 for 1 wk.
In vitro phosphorylation
5  g His-tagged paxillin   was incubated with  0.5  g of kinase in 50  l of
the kinase buffer (20 mM MOPS, pH 7.2, 10 mM MgCl2, 25 mM  –glycerol
phosphate, 5 mM EGTA, 1 mM sodium orthovanadate, 1 mM DTT) contain-
ing 40  M ATP (10  Ci  -[
32P]ATP) for 30 min at RT. The reactions were ter-
minated by adding SDS-sample buffer. The samples were subjected to SDS-
PAGE and transferred to a nitrocellulose membrane for autoradiography.
In vivo phosphorylation
Cells were incubated with [
32P]orthophosphoric acid in sodium phos-
phate–deficient MEM (Sigma-Aldrich). After 12 h, cells were harvested and
lysed with a RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% IPE-
GAL, 0.5% deoxycholate, 0.1% SDS, 5 mM EDTA, 1 mM PMSF, 10  g/ml
aprotinin, 10  g/ml leupeptin, 10  g/ml pepstatin, 500 nM okadaic acid, 1
mM  –naphthyl acid phosphate). The lysates were immunoprecipitated
with antipaxillin or anti-GFP antibodies. The immune complexes were an-
alyzed by SDS-PAGE and transferred to nitrocellulose membrane for de-
tection of phosphorylation by autoradiography.
Peptide mapping
Peptide mapping was performed as described previously (Boyle et al.,
1991; Huang et al., 2003). In brief, protein bands were cut from nitrocellu-
lose membrane and digested with trypsin (sequencing grade; Promega) in
NH4HCO3, pH 7.8, with shaking at 37 C for 8 h. The samples were dried
and washed in a speed-vac, and spotted onto cellulose plate for 2-D phos-
phopeptide mapping, using pH 8.9 buffer for electrophoresis and phos-
phochromatography buffer for TLC.
Mass spectrometry
Phosphopeptide was recovered from cellulose plates, cleaned up with a
Zip-Tip (Millipore) as described previously (Raska et al., 2002) and ana-
lyzed by a MALDI-TOF/TOF (Voyager 4700) instrument purchased from
Applied Biosystems with  -cyano-4-hydroxy-cinnamic acid as matrix. The
instrument was calibrated by external calibration using the ABI 4700 cali-
bration mixture.
Neurite outgrowth
PC-12 cells were plated on 35-mm petri dishes precoated with 10  g/ml
collagen I and cultured in RPMI 1640 containing 10% horse serum, 5%
FBS, 100 U/ml penicillin, and 100  g/ml streptomycin for overnight, and
cultured in DME supplemented with 1% FBS, 100 U/ml penicillin, and
100  g/ml streptomycin for additional 6 h. The cells were then challenged
with 100 ng/ml NGF and cultured for 4 d. The neurite outgrowth was pho-
tographed using a microscope (model IX81; Olympus) equipped with a
40  objective and a CCD camera (model C4880; Hamamatsu). Scoring
for neurite outgrowth of PC-12 cells was performed as described by Dikic
et al. (1994).
EGFP fluorescence, immunofluorescence, and microscopy
PC-12 cells expressing EGFP-paxillin   or -paxS85A were plated on MatTek
dishes (with a glass coverslip at the bottom) precoated with collagen and
treated with 100 ng/ml NGF for 48 h. EGFP epifluorescence and TIRF im-
ages were taken at 37 C using a microscope (model IX81; Olympus)
equipped with a 60 , 1.45 NA objective, a CCD camera (model C4880;
Hamamatsu), and a Metamorph software (Universal Imaging Corp.). For
immunofluorescence staining, the cells were fixed with 3% PFA and
stained for vinculin with antivinculin mAb prelabeled with Alexa 568. Vin-
culin staining and EGFP fluorescence were observed and photographed at
RT using the same system. The brightness of images were adjusted using
Photoshop software.
Protein interaction and tyrosine phosphorylation
PC-12 cells expressing EGFP-paxillin   or EGFP-paxS85A were plated on
100-mm petri dishes precoated with 10  g/ml collagen I and cultured in
normal RPMI 1640 culture medium overnight and cultured in DME sup-
plemented with 1% FBS, 100 U/ml penicillin, and 100  g/ml streptomycin
for 12 h. The cells were then induced with 100 ng/ml NGF and cultured
for 2 d. Cells were lysed with a buffer containing 50 mM Tris-HCl, pH 7.4,
1% IPEGAL, 100 mM NaCl, 5% glycerol, 5 mM EDTA, 1 mM PMSF, 10
 g/ml aprotinin, 10  g/ml leupeptin, 10  g/ml pepstatin, 500 nM okadaic
acid, 1 mM  –naphthyl acid phosphate, and 1 mM Na3VO4. The lysates
were directly mixed with SDS sample buffer, or were immunoprecipitated
with anti-GFP antibodies. Immune complexes were solubilized in SDS
sample buffer. Samples were analyzed by SDS-PAGE and transferred to ni-
trocellulose membrane to detect tyrosine phosphorylation and various pro-
tein interactions.
Online supplemental material
Fig. S1 shows that cdk5 directly phosphorylated Ser 244 on paxillin in
vitro. To demonstrate that Ser 244 on paxillin is a phosphorylation site
for cdk5, wt His-tagged paxillin   or paxS244A were phosphorylated, re-
spectively, with active cdk5/p35 and subjected to 2-D phosphopeptide
mapping analysis as described in Peptide mapping section. Fig. S2 dem-
onstrates that NGF-induced neurite extension was inhibited by a
p38MAPK inhibitor, SB203580. To test the effect of SB203580 on NGF-
induced neurite extension, PC-12 cells were plated on collagen-coated
petri dishes, treated with SB203580 as indicated for 10 min, and stimu-
lated with 100 ng/ml NGF without removing the inhibitor. Neurite out-
growth was analyzed after 96 h of NGF stimulation. Fig. S3 suggests that
the p38MAPK pathway is involved in regulating focal adhesion reorgani-
zation. To explore the role of the p38MAPK pathway in focal adhesion
dynamics, PC-12 cells were transiently transfected with EGFP vector,
Flag-p38 AF   EGFP vector, and Flag-MKK3bE   EGFP vector for 24 h,
and plated on MatTek dishes precoated with 10  g/ml collagen and
treated with 100 ng/ml NGF for 36 h. The cells were fixed and stained
with Alexa 568–labeled antivinculin antibodies. Vinculin staining and
EGFP fluorescence were viewed by epifluorescence microscopy as de-
scribed above (EGFP...and microscopy). Online supplemental material is
available at http://www.jcb.org/cgi/content/full/jcb.200307081/DC1.
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